Medical specialists from Canada tagged as investigators in clinical trials studying Recurrence
Total 110 results
-
Junliang Liu, MDSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT04670016 (Principal Investigator)
-
Karen Goddard, MDSeen in:
- British Columbia, Vancouver, British Columbia Children's Hospital
Trials:- NCT04670016 (Principal Investigator)
-
Lacey D. PitreSeen in:
- Ontario, Sudbury, Health Sciences North
Trials:- NCT03914612 (Principal Investigator)
Conditions:- Endometrial Clear Cell Adenocarcinoma;
- Endometrial Dedifferentiated Carcinoma;
- Endometrial Endometrioid Adenocarcinoma;
- Endometrial Mixed Cell Adenocarcinoma;
- Endometrial Serous Adenocarcinoma;
- Endometrial Undifferentiated Carcinoma;
- Recurrent Endometrial Adenocarcinoma;
- Recurrent Endometrial Carcinoma;
- Recurrent Endometrial Clear Cell Adenocarcinoma;
- Recurrent Endometrial Dedifferentiated Carcinoma;
- Recurrent Endometrial Endometrioid Adenocarcinoma;
- Recurrent Endometrial Mixed Cell Adenocarcinoma;
- Recurrent Endometrial Serous Adenocarcinoma;
- Recurrent Endometrial Undifferentiated Carcinoma;
- Stage III Uterine Corpus Cancer AJCC v8;
- Stage IV Uterine Corpus Cancer AJCC v8
-
Laurence Klotz, MD, FRCSCSeen in:
- Ontario, Toronto, Sunnybrook and Women's College Health Sciences Centre
- Ontario, Toronto, Toronto Sunnybrook Cancer Centre
Trials:- NCT03718260 (Principal Investigator)
- NCT05220501 (Principal Investigator)
Conditions: -
Lillian Sung, MD, PhDSeen in:
- Ontario, Toronto, The Hospital for Sick Children
Trials:- NCT04670016 (Principal Investigator)
-
Luke Lavallee, MDCM, FRCSCSeen in:
- Ontario, Ottawa, The Ottawa Hospital, General Campus
Trials:- NCT03718260 (Principal Investigator)
Conditions: -
Lynn Chang, MDSeen in:
- Ontario, Ottawa, Children's Hospital of Eastern Ontario
Trials:- NCT04670016 (Principal Investigator)
-
Macarena I. De La FuenteSeen in:
- Ontario, Toronto, University Health Network Princess Margaret Cancer Center LAO
Trials:- NCT05859334 (Principal Investigator)
-
Maged M. SalemSeen in:
- New Brunswick, Moncton, The Moncton Hospital
Trials:- NCT03914612 (Principal Investigator)
Conditions:- Endometrial Clear Cell Adenocarcinoma;
- Endometrial Dedifferentiated Carcinoma;
- Endometrial Endometrioid Adenocarcinoma;
- Endometrial Mixed Cell Adenocarcinoma;
- Endometrial Serous Adenocarcinoma;
- Endometrial Undifferentiated Carcinoma;
- Recurrent Endometrial Adenocarcinoma;
- Recurrent Endometrial Carcinoma;
- Recurrent Endometrial Clear Cell Adenocarcinoma;
- Recurrent Endometrial Dedifferentiated Carcinoma;
- Recurrent Endometrial Endometrioid Adenocarcinoma;
- Recurrent Endometrial Mixed Cell Adenocarcinoma;
- Recurrent Endometrial Serous Adenocarcinoma;
- Recurrent Endometrial Undifferentiated Carcinoma;
- Stage III Uterine Corpus Cancer AJCC v8;
- Stage IV Uterine Corpus Cancer AJCC v8
-
Magimairajan Issai Vanan, MDSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT04670016 (Principal Investigator)
-
Marguerite Mainprize, MScSeen in:
- Ontario, Thornhill, Shouldice hospital
Trials:- NCT05879770 (Sub-Investigator)
- NCT06039800 (Sub-Investigator)
Conditions: -
Marlon Hagerty, MDSeen in:
- Ontario, Thunder Bay, Thunder Bay Regional Health Sciences Centre
Trials:- NCT03718260 (Principal Investigator)
Conditions: -
Martin KorzeniowskiSeen in:
- Ontario, Kingston, Kingston Health Sciences Centre
Trials:- NCT04852887 (Principal Investigator)
Conditions: -
Maryam Al HaykiSeen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:- NCT03914612 (Principal Investigator)
Conditions:- Endometrial Clear Cell Adenocarcinoma;
- Endometrial Dedifferentiated Carcinoma;
- Endometrial Endometrioid Adenocarcinoma;
- Endometrial Mixed Cell Adenocarcinoma;
- Endometrial Serous Adenocarcinoma;
- Endometrial Undifferentiated Carcinoma;
- Recurrent Endometrial Adenocarcinoma;
- Recurrent Endometrial Carcinoma;
- Recurrent Endometrial Clear Cell Adenocarcinoma;
- Recurrent Endometrial Dedifferentiated Carcinoma;
- Recurrent Endometrial Endometrioid Adenocarcinoma;
- Recurrent Endometrial Mixed Cell Adenocarcinoma;
- Recurrent Endometrial Serous Adenocarcinoma;
- Recurrent Endometrial Undifferentiated Carcinoma;
- Stage III Uterine Corpus Cancer AJCC v8;
- Stage IV Uterine Corpus Cancer AJCC v8
-
Melanie Arbour-LevertSeen in:
- Quebec, Laval, Hopital de la Cite-de-la-Sante
Trials:- NCT03914612 (Principal Investigator)
Conditions:- Endometrial Clear Cell Adenocarcinoma;
- Endometrial Dedifferentiated Carcinoma;
- Endometrial Endometrioid Adenocarcinoma;
- Endometrial Mixed Cell Adenocarcinoma;
- Endometrial Serous Adenocarcinoma;
- Endometrial Undifferentiated Carcinoma;
- Recurrent Endometrial Adenocarcinoma;
- Recurrent Endometrial Carcinoma;
- Recurrent Endometrial Clear Cell Adenocarcinoma;
- Recurrent Endometrial Dedifferentiated Carcinoma;
- Recurrent Endometrial Endometrioid Adenocarcinoma;
- Recurrent Endometrial Mixed Cell Adenocarcinoma;
- Recurrent Endometrial Serous Adenocarcinoma;
- Recurrent Endometrial Undifferentiated Carcinoma;
- Stage III Uterine Corpus Cancer AJCC v8;
- Stage IV Uterine Corpus Cancer AJCC v8
-
Michael Leveridge, MD FRCSCSeen in:
- Ontario, Kingston, Centre for Applied Urological Research/Kingston General Hospital
Trials:- NCT01704274 (Sub-Investigator)
Conditions: -
Mohamed Eltorki, MDSeen in:
- Ontario, Hamilton, McMaster Children's Hospital
- Ontario, Hamilton, McMaster University
Trials:- NCT03361371 (Principal Investigator)
- NCT05135377 (Principal Investigator)
Conditions: -
Monia MarzoukiSeen in:
- Quebec, Montreal, Centre Hospitalier Universitaire Sainte-Justine
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT03155620 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT05071209 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT05286801 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05359237 (Principal Investigator)
- NCT04203316 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT05828069 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Malignant Glioma;
- Rhabdoid Tumor;
- Advanced Malignant Solid Neoplasm;
- Refractory Malignant Solid Neoplasm;
- Recurrent Ependymoma;
- Recurrent Ewing Sarcoma;
- Recurrent Hepatoblastoma;
- Recurrent Langerhans Cell Histiocytosis;
- Recurrent Malignant Germ Cell Tumor;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Medulloblastoma;
- Recurrent Neuroblastoma;
- Recurrent Non-Hodgkin Lymphoma;
- Recurrent Osteosarcoma;
- Recurrent Peripheral Primitive Neuroectodermal Tumor;
- Recurrent Rhabdoid Tumor;
- Recurrent Soft Tissue Sarcoma;
- Refractory Ewing Sarcoma;
- Refractory Hepatoblastoma;
- Refractory Langerhans Cell Histiocytosis;
- Refractory Malignant Germ Cell Tumor;
- Refractory Medulloblastoma;
- Refractory Neuroblastoma;
- Refractory Non-Hodgkin Lymphoma;
- Refractory Osteosarcoma;
- Refractory Peripheral Primitive Neuroectodermal Tumor;
- Refractory Rhabdoid Tumor;
- Refractory Rhabdomyosarcoma;
- Wilms Tumor;
- Langerhans Cell Histiocytosis;
- Recurrent Glioma;
- Ann Arbor Stage III Non-Hodgkin Lymphoma;
- Ann Arbor Stage IV Non-Hodgkin Lymphoma;
- Histiocytic Sarcoma;
- Juvenile Xanthogranuloma;
- Recurrent Childhood Rhabdomyosarcoma;
- Recurrent Primary Central Nervous System Neoplasm;
- Refractory Glioma;
- Refractory Primary Central Nervous System Neoplasm;
- Stage III Osteosarcoma AJCC v7;
- Stage III Soft Tissue Sarcoma AJCC v7;
- Stage IV Osteosarcoma AJCC v7;
- Stage IV Soft Tissue Sarcoma AJCC v7;
- Stage IVA Osteosarcoma AJCC v7;
- Stage IVB Osteosarcoma AJCC v7;
- Medulloblastoma;
- Refractory Lymphoma;
- Recurrent Lymphoma;
- Recurrent Alveolar Rhabdomyosarcoma;
- Refractory Alveolar Rhabdomyosarcoma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Malignant Solid Neoplasm;
- Epithelioid Sarcoma;
- Kidney Medullary Carcinoma;
- Atypical Teratoid/Rhabdoid Tumor;
- Poorly Differentiated Chordoma;
- Recurrent Atypical Teratoid/Rhabdoid Tumor;
- Recurrent Chordoma;
- Recurrent Epithelioid Sarcoma;
- Recurrent Kidney Medullary Carcinoma;
- Refractory Atypical Teratoid/Rhabdoid Tumor;
- Refractory Chordoma;
- Refractory Epithelioid Sarcoma;
- Refractory Kidney Medullary Carcinoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Acute Lymphoblastic Leukemia;
- B Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Recurrent Acute Myeloid Leukemia;
- Refractory Acute Myeloid Leukemia;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma
-
Naveen Poonai, MDSeen in:
- Ontario, London, Children's Hospital of Western Ontario
Trials:- NCT05135377 (Sub-Investigator)
Conditions: -
Neesha DhaniSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT03914612 (Principal Investigator)
Conditions:- Endometrial Clear Cell Adenocarcinoma;
- Endometrial Dedifferentiated Carcinoma;
- Endometrial Endometrioid Adenocarcinoma;
- Endometrial Mixed Cell Adenocarcinoma;
- Endometrial Serous Adenocarcinoma;
- Endometrial Undifferentiated Carcinoma;
- Recurrent Endometrial Adenocarcinoma;
- Recurrent Endometrial Carcinoma;
- Recurrent Endometrial Clear Cell Adenocarcinoma;
- Recurrent Endometrial Dedifferentiated Carcinoma;
- Recurrent Endometrial Endometrioid Adenocarcinoma;
- Recurrent Endometrial Mixed Cell Adenocarcinoma;
- Recurrent Endometrial Serous Adenocarcinoma;
- Recurrent Endometrial Undifferentiated Carcinoma;
- Stage III Uterine Corpus Cancer AJCC v8;
- Stage IV Uterine Corpus Cancer AJCC v8
-
Nidhi Kumar TyagiSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre at Hamilton Health Sciences
Trials:- NCT03914612 (Principal Investigator)
Conditions:- Endometrial Clear Cell Adenocarcinoma;
- Endometrial Dedifferentiated Carcinoma;
- Endometrial Endometrioid Adenocarcinoma;
- Endometrial Mixed Cell Adenocarcinoma;
- Endometrial Serous Adenocarcinoma;
- Endometrial Undifferentiated Carcinoma;
- Recurrent Endometrial Adenocarcinoma;
- Recurrent Endometrial Carcinoma;
- Recurrent Endometrial Clear Cell Adenocarcinoma;
- Recurrent Endometrial Dedifferentiated Carcinoma;
- Recurrent Endometrial Endometrioid Adenocarcinoma;
- Recurrent Endometrial Mixed Cell Adenocarcinoma;
- Recurrent Endometrial Serous Adenocarcinoma;
- Recurrent Endometrial Undifferentiated Carcinoma;
- Stage III Uterine Corpus Cancer AJCC v8;
- Stage IV Uterine Corpus Cancer AJCC v8
-
Normand Laperriere, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT04670016 (Principal Investigator)
-
Patricia Couroux, MDSeen in:
- Ontario, Mississauga, Cliantha Research
Trials:- NCT06264141 (Principal Investigator)
Conditions: -
Patrick Veit-Haibach, M.D.Seen in:
- Ontario, Toronto, University Health Network - Princess Margaret Cancer Centre
Trials:- NCT04644822 (Sub-Investigator)
Conditions: -
Rebecca Deyell, MD, FRCPCSeen in:
- Vancouver, BC Children's Hospital Research Institute
Trials:- NCT04901702 (Principal Investigator)
Conditions:- Refractory Malignant Solid Neoplasm;
- Recurrent Ewing Sarcoma;
- Recurrent Hepatoblastoma;
- Recurrent Malignant Germ Cell Tumor;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Neuroblastoma;
- Recurrent Osteosarcoma;
- Recurrent Peripheral Primitive Neuroectodermal Tumor;
- Recurrent Rhabdoid Tumor;
- Recurrent Rhabdomyosarcoma;
- Recurrent Soft Tissue Sarcoma;
- Refractory Ewing Sarcoma;
- Refractory Hepatoblastoma;
- Refractory Malignant Germ Cell Tumor;
- Refractory Neuroblastoma;
- Refractory Osteosarcoma;
- Refractory Peripheral Primitive Neuroectodermal Tumor;
- Refractory Rhabdoid Tumor;
- Refractory Rhabdomyosarcoma;
- Refractory Soft Tissue Sarcoma;
- Recurrent Solid Tumor;
- Recurrent Wilms Tumor
-
Robert Turcotte, MDSeen in:
- Quebec, Montréal, McGill University Health Centre
Trials:- NCT03295981 (Principal Investigator)
Conditions: -
Robert Wolfson, MDSeen in:
- Ontario, Toronto, Toronto Sunnybrook Cancer Centre
Trials:- NCT03718260 (Sub-Investigator)
Conditions: -
Rodney H Breau, MDSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT05169112 (Principal Investigator)
Conditions: -
Sarah Cohen-Gogo, MD, PhDSeen in:
- Ontario, Toronto, The Hospital for Sick Children
Trials:- NCT04901702 (Sub-Investigator)
Conditions:- Refractory Malignant Solid Neoplasm;
- Recurrent Ewing Sarcoma;
- Recurrent Hepatoblastoma;
- Recurrent Malignant Germ Cell Tumor;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Neuroblastoma;
- Recurrent Osteosarcoma;
- Recurrent Peripheral Primitive Neuroectodermal Tumor;
- Recurrent Rhabdoid Tumor;
- Recurrent Rhabdomyosarcoma;
- Recurrent Soft Tissue Sarcoma;
- Refractory Ewing Sarcoma;
- Refractory Hepatoblastoma;
- Refractory Malignant Germ Cell Tumor;
- Refractory Neuroblastoma;
- Refractory Osteosarcoma;
- Refractory Peripheral Primitive Neuroectodermal Tumor;
- Refractory Rhabdoid Tumor;
- Refractory Rhabdomyosarcoma;
- Refractory Soft Tissue Sarcoma;
- Recurrent Solid Tumor;
- Recurrent Wilms Tumor
-
Sarah J. McKillopSeen in:
- Alberta, Edmonton, University of Alberta Hospital
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT04089358 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Childhood Malignant Neoplasm
Clinical Trials on Recurrence
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Paracelsus Medical UniversityHeinrich-Heine University, Duesseldorf; Poznan University of Medical Sciences; University Hospital of Ferrara and other collaboratorsCompletedToxicity | Local Neoplasm RecurrenceAustria
-
Chinese PLA General HospitalRecruitingHCC | Recurrence TumorChina
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence
-
German Centre for Assessment and Evaluation of...Not yet recruitingComplication | Continence | Potency | Biochemical RecurrenceGermany
-
General Hospital GroeningeUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; University Hospital, Ghent and other collaboratorsNot yet recruiting
-
Dallas VA Medical CenterTerminatedSolid Tumors | Cancer RecurrenceUnited States
-
PhytoHealth CorporationCompletedNeoplasm Metastasis | Neoplasm RecurrenceTaiwan
-
The University of Hong KongHealth and Medical Research FundRecruitingCancer | Fear of Cancer Recurrence | PsychooncologyHong Kong
-
The University of Hong KongNot yet recruitingCancer | Fear of Cancer Recurrence